Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

Register to chat with this document.

RNS - OSE Immunotherapeutics fait un point clinique sur Tedopi®, vaccin contre le cancer à base de néo-épitopes, dans le cancer du pancréas et dans le cancer du poumon non à petites cellules

Company: OSE Immunotherapeutics Date: 2025-06-02 Language: French Register to download

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method: